Category
Drug Product CDMOs
Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
About Drug Product Manufacturing
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Companies (1365)
Hangzhou Jiuyuan Gene Engineering Co., Ltd
China
Hangzhou Jiuyuan Gene Engineering Co., Ltd., a subsidiary of Huadong Medicine Co., Ltd., is a Chinese biopharmaceutical company that was among the first national high-tech enterprises to realize biopharmaceutical manufacturing. The company produces finished dosage forms including oncology injections and is FDA-registered. It operates as part of the larger Huadong Medicine group which includes Doer Biologics.
Biologics Drug SubstanceBiologics Drug ProductBiologics Manufacturing
Hanmi Pharm. Co. Ltd
South Korea
Hanmi Pharmaceutical is a major South Korean pharmaceutical company providing comprehensive CDMO services across the entire pharmaceutical lifecycle. The company operates through Paltan Smart Plant (producing 6+ billion chemical drug tablets annually), Pyeongtaek Bioplant (FDA-approved biopharmaceutical manufacturing with 12,500L bioreactors), and Hanmi Fine Chemical (API and raw materials including mRNA cap analogs, NTP, and lipids). Hanmi has partnerships with global pharma companies including Lilly, Roche, and Sanofi.
Small Molecule APISmall Molecule Drug ProductOral Solid Dose
Frequently Asked Questions
What is drug product manufacturing?+
Drug product manufacturing converts APIs into final dosage forms for patients. The process includes formulation development (choosing excipients, optimizing bioavailability), process development (granulation, compression, coating, filling), analytical method development, stability testing, and scale-up to commercial volumes. It also covers packaging and labeling.
What dosage forms can drug product CDMOs produce?+
Common dosage forms include tablets (immediate-release, modified-release, orally disintegrating), capsules (hard gelatin, HPMC, softgel), sterile injectables (lyophilized, liquid), semi-solids (creams, ointments, gels), liquids (solutions, suspensions, syrups), and specialty forms (transdermal patches, inhalers, suppositories, implants). Most CDMOs specialize in 2-3 dosage forms rather than offering all.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
